Below are the most recent publications written about "Alopecia" by people in Profiles.
-
Douglas A, Brockmeyer K, Iwuala C, Ohanenye C, Ekeh O, Cole Y, Sangobiyi M, Zhan T, Taylor S, Nikbakht N. Knowledge gaps in hairstyling practices and hair loss within the African American community. Arch Dermatol Res. 2024 Jan 10; 316(2):68.
-
Doolan BJ, Rayinda T, Chiu FP, McGrath JA, Onoufriadis A. A review of genotrichoses and hair pathology associated with inherited skin diseases. Br J Dermatol. 2023 07 17; 189(2):154-160.
-
Lalagianni N, McSweeney SM, Christou EAA, Rayinda T, Ferguson J, Stefanato CM, McGrath JA, Tziotzios C. Actinic lichen planopilaris: a new variant of lichen planopilaris triggered by ultraviolet radiation. Clin Exp Dermatol. 2023 02 02; 48(2):158-160.
-
Cheng CW, ElSahwi K, Borowsky ME, Aikman N, Hicks V. Sex cord stromal tumor presenting with hair loss in postmenopausal women. Int J Gynaecol Obstet. 2022 10; 159(1):313-315.
-
Stefanski HE, Xing Y, Nicholls J, Jonart L, Goren E, Taylor PA, Mills AA, Riddle M, McGrath J, Tolar J, Hollander GA, Blazar BR. P63 targeted deletion under the FOXN1 promoter disrupts pre-and post-natal thymus development, function and maintenance as well as induces severe hair loss. PLoS One. 2022; 17(1):e0261770.
-
Javle M, Roychowdhury S, Kelley RK, Sadeghi S, Macarulla T, Weiss KH, Waldschmidt DT, Goyal L, Borbath I, El-Khoueiry A, Borad MJ, Yong WP, Philip PA, Bitzer M, Tanasanvimon S, Li A, Pande A, Soifer HS, Shepherd SP, Moran S, Zhu AX, Bekaii-Saab TS, Abou-Alfa GK. Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study. Lancet Gastroenterol Hepatol. 2021 10; 6(10):803-815.
-
Rayinda T, McSweeney SM, McFadden JP, White IR, McGrath JA, Tziotzios C. There is no proven association between sensitization to benzyl salicylate and frontal fibrosing alopecia. Contact Dermatitis. 2021 10; 85(4):483-484.
-
Tziotzios C, Stefanato CM, McGrath JA, Fenton DA. Frontal fibrosing alopecia should be renamed to lichen planopilaris of Kossard. J Am Acad Dermatol. 2019 08; 81(2):e53.
-
Tziotzios C, Petridis C, Dand N, Ainali C, Saklatvala JR, Pullabhatla V, Onoufriadis A, Pramanik R, Baudry D, Lee SH, Wood K, Liu L, Seegobin S, Michelotti GA, Lwin SM, Christou EAA, Curtis CJ, de Rinaldis E, Saxena A, Holmes S, Harries M, Palamaras I, Cunningham F, Parkins G, Kaur M, Farrant P, McDonagh A, Messenger A, Jones J, Jolliffe V, Ali I, Ardern-Jones M, Mitchell C, Burrows N, Atkar R, Banfield C, Alexandroff A, Champagne C, Cooper HL, Va??-Galv?n S, Molina-Ruiz AM, Perez NO, Patel GK, Macbeth A, Page M, Bryden A, Mowbray M, Wahie S, Armstrong K, Cooke N, Goodfield M, Man I, de Berker D, Dunnill G, Takwale A, Rao A, Siah TW, Sinclair R, Wade MS, Dlova NC, Setterfield J, Lewis F, Bhargava K, Kirkpatrick N, Estivill X, Stefanato CM, Flohr C, Spector T, Watt FM, Smith CH, Barker JN, Fenton DA, Simpson MA, McGrath JA. Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02. Nat Commun. 2019 03 08; 10(1):1150.
-
Tziotzios C, Ainali C, Holmes S, Cunningham F, Lwin SM, Palamaras I, Bhargava K, Rymer J, Stefanato CM, Kirkpatrick N, Vano-Galvan S, Petridis C, Fenton DA, Simpson MA, Onoufriadis A, McGrath JA. Tissue and Circulating MicroRNA Co-expression Analysis Shows Potential Involvement of miRNAs in the Pathobiology of?Frontal Fibrosing Alopecia. J Invest Dermatol. 2017 11; 137(11):2440-2443.